INSULIN ADMINISTRATION | ||||||
---|---|---|---|---|---|---|
Preparation | Brand | Route | Adminis– tration |
Mixing Insulins | Comments | |
RAPID-ACTING | ||||||
insulin | Afrezza | Rx | oral inh |
At the beginning of a meal | — | Loss of drug effect if inhaler is mishandled. See full labeling. |
insulin aspart | Fiasp | Rx | SC, CSII, IV* | Individualize. SC: at start of meal or within 20mins after starting meal | Do not dilute/mix with other insulins | Should look clear, colorless. SC: use with intermediate or long-acting insulin. |
NovoLog | Rx | SC, CSII, IV* | Within 5−10mins before a meal | SC: May mix with NPH insulin. Draw NovoLog into syringe first. Inject immediately after mixing. May dilute with Insulin Diluting Medium for NovoLog to 1:10 (U‑10) or 1:2 (U‑50) concentrations. CSII: Do not dilute or mix with other insulins IV: Do not mix with other insulins |
CSII: Change inj site at least every 3 days and reservoir at least every 6 days. | |
insulin glulisine | Apidra | Rx | SC, CSII, IV* | Individualize. SC: 15mins before meal or within 20mins after starting meal | SC: May mix with NPH insulin. Draw Apidra into syringe first. Inject immediately after mixing. CSII: Do not dilute or mix with other insulins IV: Do not mix with other insulins |
SC: use with intermediate or long-acting insulin. CSII: Change inj site at least every 48hrs and reservoir at least every 2 days. |
insulin lispro | Admelog | Rx | SC, IV*, CSII | Within 15mins before a meal or immedi–ately after a meal | Do not dilute/mix with other insulins | SC: generally used with intermediate or long-acting insulin. CSII: Change inj site at least every 3 days and reservoir at least every 7 days. |
Humalog | Rx | SC, IV*†, CSII† | Within 15mins before a meal or immedi–ately after a meal | SC: May mix Humalog U-100 with NPH insulin. Draw Humalog into syringe first. Inject immediately after mixing. May dilute with STERILE DILUENT for Humalog to 1:10 (U‑10) or 1:2 (U‑50) concentrations. CSII: Do not dilute or mix with other insulins |
SC: generally used with intermediate or long-acting insulin. CSII: Change inj site at least every 3 days and reservoir at least every 7 days. |
|
insulin lispro-aabc | Lyumjev | Rx | SC, IV*†, CSII† | At the start of a meal or within 20mins after starting a meal | Do not dilute/mix with other insulins | SC: use with intermediate or long-acting insulin. IV: for Lyumjev U-100 only. Do not give U-200 intravenously. CSII: for Lyumjev U-100 only. Change inj site according to manufacturer’s user manual, and reservoir at least every 9 days or according to the pump user manual, whichever is shorter. |
SHORT-ACTING | ||||||
insulin injection regular (R) | Humulin R U‑100 | OTC | SC, IV* | Individ– ualize. SC: ~30mins before a meal |
SC: May mix with NPH insulin only. Draw Humulin R (clear) into syringe first then NPH. Inject immediately. | Use syringes marked with U‑100. SC: use with intermediate or long-acting insulin. |
Humulin R U‑500 |
Rx | SC | Individ– ualize. ~30mins before a meal |
Do not dilute/mix with other insulins | Caution with dosage. Should look clear, colorless. Use with U-500 insulin syringes. | |
Novolin R | OTC | SC, IV* | Individualize. SC: ~30mins before a meal | SC: May mix with NPH insulin only. Draw Novolin R (clear) into syringe first then NPH. Inject immediately. | Use syringes marked with U‑100. SC: use with intermediate or long-acting insulin. |
|
INTERMEDIATE-ACTING | ||||||
insulin isophane suspension (NPH) | Humulin N | OTC | SC | Individ– ualize |
May mix with Humalog or Humulin R. Draw clear insulin into syringe first then Humulin N. Inject immediately. | Rotate vial or pen until uniformly white and cloudy. Use syringes marked with U‑100. |
Novolin N | OTC | SC | Individ– ualize |
May mix with regular insulin only. Draw regular insulin (clear) into syringe first then Novolin N. Inject immediately. | Roll vial in horizontal position 10 times or move pen up and down 20 times until uniformly white and cloudy. Inject immediately. | |
SHORT- AND INTERMEDIATE-ACTING MIXTURES | ||||||
insulin aspart protamine/ insulin aspart |
NovoLog Mix 70/30 |
Rx | SC | Twice daily within 15mins before a meal | Do not mix with other insulins | Roll vial, prefilled syringe 10 times until uniformly cloudy. |
insulin isophane suspension (NPH)/ regular insulin (R) | Humulin 70/30 | OTC | SC | Individ–ualize. ~30–45mins before a meal | Do not mix with other insulins | Rotate vial or pen until uniformly white and cloudy. Use syringes marked with U‑100. |
Novolin 70/30 | OTC | SC | Individ–ualize. Twice daily ~30mins before a meal | Do not mix with other insulins | Roll vial in horizontal position 10 times or move pen up and down 20 times until uniformly white and cloudy. Inject immediately. | |
insulin lispro protamine/ insulin lispro |
Humalog Mix 50/50 |
Rx | SC | Individualize. Usually twice daily within 15mins before a meal | Do not mix with any other insulins | Rotate vial or pen 10 times until uniformly white and cloudy. Inject immediately. |
Humalog Mix 75/25 |
||||||
LONG-ACTING | ||||||
insulin degludec | Tresiba | Rx | SC | Once daily at any time of day | Do not dilute or mix with other insulins | Should look clear, colorless. |
insulin detemir | Levemir | Rx | SC | Once daily with PM meal or at bedtime or twice daily (AM and PM) | Do not dilute or mix with other insulins | Should look clear, colorless. For T1DM, must be used with rapid- or short-acting insulin. |
insulin glargine | Basaglar | Rx | SC | Once daily at the same time every day | Do not dilute or mix with other insulins | Should look clear, colorless. |
Lantus | ||||||
Rezvoglar | ||||||
Semglee | ||||||
Toujeo | ||||||
LONG-ACTING MIXTURES | ||||||
insulin degludec/ liraglutide |
Xultophy 100/3.6 | Rx | SC | Once daily at same time each day, with or without food | Do not dilute/mix with other insulins or solutions | Should look clear, colorless. Not for use in T1DM patients. |
insulin glargine/ lixisenatide |
Soliqua 100/33 | Rx | SC | Once daily within the hour prior to first meal | Do not dilute or mix with other insulins or solutions | Should look clear, colorless to almost colorless. |
NOTES | ||||||
Key: CSII = continuous subcutaneous insulin infusion; T1DM = type 1 diabetes mellitus * IV to be used in a clinical setting under proper medical supervision. †IV and CSII administration for U-100 only. Rate of insulin absorption, onset and duration of action may be affected by the injection site, blood supply, temperature, exercise, and other variables. Caution with changes in strength, manufacturer, preparation, species of insulin source. Not an inclusive list of medications and/or dosing instructions. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling. (Rev. 7/2023) |
Please login or register first to view this content.